In mouse and human preimplantation development, pyruvate is consumed preferentially during early embryogenesis; however, during the morula and blastocyst stages, glucose is the preferred energy substrate. Studies have suggested that the glycolytic enzymes, hexokinase and glucose phosphate isomerase, are important enzymes in glucose metabolism during these later stages of human and mouse preimplantation development. In order to investigate the genetic activities of these enzymes in late-stage mouse embryos developing in vitro, we analysed hexokinase and glucose phosphate isomerase transcription activities by qualitative RNA assays using reverse transcriptase-nested polymerase chain reaction amplification of individual mouse morulae and early blastocysts incubated in glucose/phosphate-free preimplantation stage one (P1) medium and glucose/phosphate-containing human tubal fluid (HTF) medium. We observed an increased incidence of hexokinase transcripts in the population of blastocysts compared with morulae, and differences in transcript incidence between early blastocysts developing in HTF medium and in P1 medium. In contrast, glucose phosphate isomerase transcripts were consistantly present in all embryos analysed, and appear to be constitutively expressed during late-stage mouse embryogenesis. The different activity patterns of the two glycolytic genes may reflect different mechanisms of gene regulation or differential transcript stability during the later stages of mouse preimplantation development.
Introduction
formation (Brown and Whittingham, 1991; Martin and Leese, 1995) . In both mice and humans, the preimplantation embryo survives
The conversion from a pyruvate-based metabolism to one independently within the environments of the tubal lumen and that primarily utilizes glucose occurs during a period of uterus prior to establishing a maternal communication at increasing energy requirements as the embryo proceeds in implantation. In order for it to adapt to its changing environment development. A profile of enzymatic activity during human and meet the metabolic demands incurred during different preimplantation development by Martin et al. (1993) suggests stages of development, the preimplantation embryo must utilize that hexokinase (HX) and glucose phosphate isomerase (GPI) different metabolic systems to metabolize different energy have activity patterns that correlate with glucose utilization by substrates (Bavister, 1995) . During both the mouse and human the embryo. HX was observed to decline in activity during early cleavage stages of development, pyruvate is the preferred early embryogenesis until the 8-16-cell stage, followed by a substrate for energy metabolism (Brinster, 1965; Biggers et al., rapid increase in activity to the blastocyst stage. A comparable 1967; Whitten and Biggers, 1968; Leese and Barton, 1984;  pattern has been observed during mouse development. HX Gardner and Leese, 1986; Conaghan et al., 1993) . At the 6-activity dramatically increases during the stages of morula 8-cell stage, a switch in energy substrate preference from compaction and blastocyst formation to maximum levels in pyruvate to glucose occurs, and glucose is consumed as the the mouse blastocyst (Brinster, 1968; Hooper and Leese, 1989 ; predominant energy source through the blastocyst stage (Leese Ayabe et al., 1994; Houghton et al. 1996) . In a similar pattern, and Barton, 1984; Gardner and Leese, 1986; Conaghan et al., the enzymatic activity of GPI was observed to decrease during 1993). Although pyruvate is consumed preferentially before human embryonic development from the 4-16-cell stage, the 6-8-cell stage, mouse embryos developing in vitro require stabilize through the compacting morula stage, and increase glucose exposure early in development to support the moruladuring formation of the blastocyst (Martin et al., 1993) . early blastocyst transition and allow for optimal blastocyst HX catalyses the first enzymatic step in glycolysis, utilizing ATP to phosphorylate glucose to glucose 6-phosphate. It is *Presented in part as an abstract at the 42nd Annual Meeting of the consistently elevated in mammalian tissues that depend upon Society of Gynecologic Investigation, Chicago, IL, USA, March 15-18, 1995. glucose for energy production (Griffen et al., 1992; Vaulont contribute to the dramatic rise in HX enzyme activity at the the DNA and Protein Synthesis Laboratory of the Beckman Center, morula-blastocyst transition.
Stanford University School of Medicine, CA, USA.
GPI catalyses the second step in glycolysis which intercon-
Embryo collection
verts glucose 6-phosphate and fructose 6-phosphate (Stryer, The study was approved by the Administrative Panel on Laboratory 1988). West (1993) the transition to functional placentation.
Embryo collection and analysis was conducted in a series of three
The temporal patterns of these enzymes' activities in the sessions performed on three separate occasions. In each experimental mouse and human embryo are similar to the pattern of glucose session, 10 6-8 week old embryo donor B6C3F1/Sim (C57BL/ uptake observed in both mouse and human embryos, and 6ϫC3H/He) females (Simonsen Laboratories Inc, Gilroy, CA, USA) suggest that HX and GPI are active participants in the transition underwent ovulation stimulation and mating followed by zygote to embryonic utilization of glucose. In order to investigate the retrieval. Each donor female received pregnant mare's serum gonadotrophin (PMSG) 10 IU (0.1 ml) injected i.p. in the morning, followed genetic activities of these enzymes during the period of by human chorionic gonadotrophin (HCG) 10 IU (0.1 ml) 54 h later.
increasing glucose utilization in the critical morula to blastocyst 
Materials and methods
50% of the normally developing embryos in each microdrop culture cDNA target sequence and PCR primer design were retrieved for analysis after reaching the morula/early blastocyst stages at 72 h in culture. The remaining embryos were collected at cDNA sequences from the 4198 bp mouse cDNA of hexokinase (HX) the fully expanded and hatched blastocyst stages after 96 h in (Arora et al., 1990) and the 1985bp mouse cDNA of glucose phosphate culture. Embryo thermolysis and reverse transcription reactions were isomerase (GPI), otherwise referred to as neuroleukin (Gurney et al., performed on individual embryos immediately after their removal 1986) were selected for reverse transcription and PCR amplification from culture. Over a series of three sessions, a total of 50 P1-cultured (RT-PCR). Nested sets of primer pairs were designed to amplify morulae, 41 HTF-cultured morulae, 34 P1-cultured early blastocysts, products spanning exon-intron boundaries to differentiate the desired and 39 HTF-cultured early blastocysts were obtained for analysis at 533 bp HX and 135 bp GPI cDNA sequences from the larger genomic the 72 h timepoint. At the 96 h timepoint, a total of 17 P1-cultured DNA products containing introns. The nucleotide sequence of the expanded blastocysts, 24 HTF-cultured expanded blastocysts, 26 P1-533 bp RT-nested PCR product amplified from the mouse cDNA of cultured hatched blastocysts, and 13 HTF-cultured hatched blastocysts HX spans 5 exons, and contains the coding sequences for the putative were obtained for analysis. ATP-binding and glucose-binding domains (Arora et al., 1990; Stoffel et al., 1992) . The nucleotide sequence of the GPI RT-nested PCR Culture media mouse cDNA product extends across the exon-intron boundaries between exons 1 and 2. Since the genomic sequence of the mouse
The culture media utilized in this study were commercially prepared by Irvine Scientific Inc. (Santa Ana, CA, USA). HTF, originally GPI gene is not published, we utilized the genomic structure of the human GPI gene (Walker et al., 1990) to design our targeted sequences described by Quinn et al. (1985) , has the following composition: 2.78 mM glucose; 0.37 mM potassium phosphate, monobasic; 101.6 for RT-nested PCR. The cDNAs of both mouse and human GPI (neuroleukin) share homology at the spliced interface of exons 1 and mM sodium chloride; 4.69 mM potassium chloride; 0.20 mM magnesium sulphate, anhydrous; 2.04 mM calcium chloride, anhydrous; 25 2, allowing for the design of targeted sequences that are homologous in both species. mM sodium bicarbonate; 0.33 mM sodium pyruvate; 21.4 mM sodium lactate; penicillin-G 100 IU/ml and streptomycin sulphate 50 µg/ml. The primers designed for reverse transcription and PCR amplifica- HX ϭ hexokinase; GPI ϭ glucose phosphate isomerase. a Nucleotide position within human cDNA sequences (Nishi et al., 1988; Walker et al., 1990) and the shared homology with mouse cDNA sequences (Gurney et al., 1986; Arora et al., 1990) .
Preimplantation stage one (P1) medium (Irvine Scientific Inc.) has batches containing 0.1 µM of the 5Ј upstream outer primer for either HX or GPI and 50 µl aliquots were placed in individual thin-walled the same composition as HTF media except for the addition of 0.05 mM taurine, 0.15 mM; 0.15 mg/l sodium citrate and the exclusion reaction tubes. The reactions were overlaid with Nujol oil to prevent evaporation and then amplified by PCR for 30 cycles in a DNA of glucose and potassium phosphate.
Thermal Cycler (Perkin Elmer Cetus). Each cycle included denaturaThermolysis of embryos and reverse transcription tion at 94°C for 45s, reannealing of primers to target sequences at 55°C for 45 s, and primer extension at 72°C for 1 min. Gene-specific cDNA templates were reverse transcribed from RNAs using primers designed from the 3Ј ends of the GPI and HX targeted An aliquot (5 µl) of first round reaction product was used as template for a second round of PCR amplification performed with sequences, rather than with random hexamer or oligo-dT primers. A single RT master mix (5 mM MgCl 2 ; 1 mM each dGTP, dTTP, dATP, the upstream and downstream nested pairs of primers specific for GPI or HX at 0.2 µM concentrations, using reaction buffers and dCTP; 50 mM KCl; 10 mM Tris-HCl, pH 8.3) with 0.5 µM of each 3Ј downstream outer primer was prepared for each group of embryos amplification conditions as described previously in the first round PCR analysis. The final nested RT-PCR products were electrophoresed as described for the GeneAmp RNA PCR Kit (Perkin Elmer Cetus Inc, Norwalk, CT, USA). The RT master mix was aliquoted (18 µl) in 1ϫ TBE on 2.5% agarose gels containing ethidium bromide (~0.5 µg/ml) and photographed. into individual PCR reaction tubes to minimize pipetting error and provide uniformity between individual reactions. Two drops of sterile Nujol oil were added to cover the reaction and prevent evaporation.
Confirmation of RT-nested PCR products by nucleotide sequencing A positive control containing 2 ng of embryonic stem cell RNA was added to a single aliquoted RT master mix and analysed with each
To confirm that the RT-nested PCR products for HX (533 bp) and batch of embryo assays. The negative control contained RT mix only, GPI (135 bp) were the specific mouse cDNA sequences targeted for without RNA template. Control reactions were handled exactly as amplification, the individual RT-PCR products underwent nucleotide the sample reactions throughout the entire sequence of nested RTsequencing. The RT-nested PCR products shown in Figures 1 and 2 PCR analyses.
were isolated from agarose gels using the QIAEX Gel Extraction Kit Embryos were examined under light microscopy and classified (Quiagen Inc, Chatsworth, CA, USA) and cloned into the pCR™II according to developmental stage and general morphology. Following vector (Invitrogen, Inc, San Diego, CA, USA) followed by plasmid incubation, each individual embryo was removed from the media by amplification and repurification. Sequencing of the products was sterile micropipette and washed twice in drops of sterile water for performed by the dideoxy method as described by s to remove residual media. The single embryo was then (1977) using the M13 universal primer for one strand and the M13 placed into a PCR reaction tube containing the aliquoted RT mix reverse sequencing primer for the opposite strand. Computerized under oil as described above. The reaction tube was visualized alignment and comparison of the 135 bp GPI and 533 bp HX under microscopy to confirm the presence of the embryo. Embryos nucleotide sequences from the RT-nested PCR products with the underwent thermolysis to release nucleic acids by heating the reaction published mouse cDNA consensus sequences of the targeted cDNAs mix under PCR oil for 1 min at 100°C (Kumazaki et al., 1994) .
in GPI and HX confirmed sequence homology, and the specificity of Reaction tubes were then placed on ice for 30 s before adding 20 IU the RT-PCR expression analyses. of RNase inhibitor and 2. 96 h in culture. After 72 h in culture, rates of embryo growth 1 mM each of dATP, dCTP, dGTP, and dTTP and 2.5 IU of Taq were similar (P ϭ 0.26), and the population was composed of polymerase) as described in the GeneAmp RNA PCR Kit (Perkin Elmer Cetus). The PCR reaction buffer was prepared as two separate morulae and early blastocysts defined as Ͻ50% blastocoel were determined by electrophoretic separation of the RTnPCR products. As shown in the examples from the HX and GPI RT-nPCR assays performed on individual morulae and were negative for both HX and GPI expression and were assumed to contain either no embryo, or possibly a non-viable embryo with no evidence of genetic expression. These two expansion. After 96 h in culture, the population was composed of fully expanded blastocysts and hatched blastocysts. Embryos samples were deleted from the data analysis. The reaction conditions for each group of embryo analyses were monitored that appeared to be arrested or degenerating were not included in the analysis. In total, 242 late-stage embryos, 115 cultured in using positive and negative controls specific for GPI and HX, in order to detect the presence of contamination (a positive glucose/phosphate-containing HTF media and 127 in glucose/ phosphate-free P1 media, underwent HX and GPI transcription negative control) or unsuitable reaction conditions (a negative positive control). As shown in Table II , the number of positive analysis. Results of the qualitative gene expression assays P1-cultured embryos, 82% (14/17) of the expanded blastocysts between the morulae and the late-stage blastocysts (expanded and hatched) in either HTF (P ϭ 0.04) or P1 media (P ϭ 0.01) showed a significant increase in HX gene expression and negative results were tallied for HX mRNA transcripts and incubation condition (HTF glucose/phosphate-positive; P1 during development, regardless of the culture environment. glucose/phosphate-negative).
Our data reveal different profiles of transcript incidence for
Discussion
the genes that encode HX and GPI during the embryonic stages of morula compaction, blastocyst expansion, and blastocyst Our data reveal different profiles of mRNA transcript incidence for the genes that encode hexokinase (HX) and glucose hatching. GPI mRNA transcripts were observed in 100% of the 242 viable embryos analysed. In contrast, HX mRNA phosphate isomerase (GPI) during the morulae and blastocyst stages of development. Gene transcripts encoding GPI are transcripts were observed to vary between embryos of different developmental stages as well as between the different populauniformly expressed in morulae and blastocysts, and their presence is not significantly influenced by the culture environtions of early blastocysts developing in glucose/phosphatecontaining HTF and glucose/phosphate-free P1 media.
ment. This consistency of transcript activity suggests that GPI is constitutively expressed during late-stage mouse embryogenAfter 72 h of culture in HTF, 61.5% (24/39) of the morulae and 82% (32/39) of early blastocysts had evidence of HX esis or, if GPI transcription is variable, an abundance of highly stable RNA transcripts are present during compaction and mRNA transcripts (P ϭ 0.07). In the group of P1-cultured embryos, 58% (29/50) of the morulae and 44% (15/34) of blastocyst formation. In contrast, the incidence of HX mRNA transcripts varies throughout the morulae and blastocyst stages, early blastocysts had expressed HX gene transcripts. Although there were no significant differences observed in the incidences suggesting that HX mRNAs transcripts are less stable and less abundantly transcribed in the embryo than GPI. of HX gene transcripts between the morulae and early blastocysts cultured in the same media after 72 h, a difference in
The incidence of HX gene transcription increases as embryos progress from the morulae to the late blastocyst stages. During HX gene expression (P ϭ 0.015) was observed between all HTF-cultured embryos (72%; 56/78) and all P1-cultured this developmental progression, HX mRNA transcripts are observed more frequently in early blastocysts cultured in HTF embryos (52%; 44/84). This was due to a significant difference (P ϭ 0.0013) between the incidence of HX gene expression medium than in P1-cultured early blastocysts; however, in the later blastocyst stages, HX mRNA transcripts are observed observed in HTF-cultured early blastocysts (82%; 32/39) and in P1-cultured early blastocysts (44%; 15/34). However, there with comparable frequencies in both media. In embryos that ultimately develop to the expanded blastocyst stage, the was no difference in HX gene expression between HTFcultured morulae (61%; 24/39) and P1-cultured morulae (58%; majority have evidence of HX mRNA transcripts, regardless of culture environment. As the embryos progressed through 29/50).
After 96 h of culture in HTF, 75% (18/24) of the expanded hatching, all of the HTF-cultured hatched blastocysts (13/13) and 85% (22/26) of the P1-cultured hatched blastocysts had blastocysts and 100% (13/13) of the hatched blastocysts expressed HX gene transcripts (P ϭ 0.07). In the cohort of detectable HX transcripts. The increased incidence of HX gene transcripts observed in the expanded and hatched blastocysts are not known. Several candidate factors, specifically glucose, insulin, glucose-6-phosphate, inorganic phosphate, and cAMP suggests that the majority of viable embryos actively transcribe stable HX transcripts as they progress through blastocyst have been identified to regulate HX transcription in various tissues (Griffen et al., 1992; Yokomori et al., 1992) . Glucose expansion and hatching regardless of the culture environment. It is possible that the small minority (4/26) of P1-cultured and insulin response elements (GRE and IRE) have been identified within the regulatory regions of the genes for two hatched blastocysts with undetectable HX transcripts are metabolically deficient, and their prognosis for further development glycolytic enzymes, L-type pyruvate kinase and phosphoenolpyruvate carboxykinase, respectively (Vaulont and Kahn, and successful implantation may be limited.
Differences in the media composition may be responsible 1994). Based on our data, if similar glucose response elements reside in the HX and GPI regulatory regions, they may not be for directly or indirectly exerting an environmental glucose/ phosphate-influence upon embryonic cell growth, and hence active regulators of transcription during mouse preimplantation embryogenesis. influence cellular HX transcription during early blastocyst formation. Martin and Leese (1995) showed that cultured Two glucose transporters, GLUT1 and GLUT2, have been shown to be expressed during mouse embryogenesis (Hogan mouse embryos required exposure to glucose for at least 24 h to develop into blastocysts with optimal numbers of cells. . GLUT1 is expressed thoughout development, whereas GLUT2 is expressed from the 8-cell stage onward, in this study, the lower incidence of HX gene expression observed in P1-cultured early blastocysts after 72 h in culture may parallel with the period of HX activation and increased embryonic glucose consumption (Hogan et al., 1991) . The reflect the possibility that some morulae and early blastocysts cultured in the glucose/phosphate-free P1 medium have a temporal pattern of GLUT2 activity during embryonic glucose utilization suggests a possible role in glucose uptake, and reduced number of HX transcriptionally-active cells. Therefore, the P1-cultured early blastocysts may be anticipated to tranpossibly an interaction with HX. In the yeast species, Kluyveromyces lactis, expression of the HX gene is required for scribe less total embryonic HX RNA than embryos that develop in a glucose/phosphate-containing HTF medium for transcriptional regulation of the obligatory glucose transporter, RAG1 (Prior et al., 1993) . A similar relationship may exist in the same duration.
Embryo condition may explain some of the differences the glucose metabolism of mammalian cells.
In conclusion, our data reveal differences in the incidence observed between embryos cultured in the different environments. HX gene transcripts may be more abundant in healthier, of HX transcripts observed in embryos between the morulae and blastocyst stages, and between early blastocysts developing developing embryos due to an increased number of metabolically active cells with active HX transcription and increased in HTF medium and early blastocysts developing in P1 medium. In contrast, GPI transcripts are consistently present HX mRNA transcript stability. In comparison with healthier embryos, some normal-appearing embryos may have fewer in all embryos analysed, and appear to be constitutively expressed during late-stage mouse embryogenesis. The differviable cells with reduced genome activity and deficient transcription that produce a reduced number of less stable mRNA ent activity patterns of the two glycolytic genes appear to reflect different mechanisms of gene regulation or different transcripts. The development of this subpopulation of abnormal embryos may become arrested or retarded, eventually dropping transcript stabilities during the later stages of mouse preimplantation. Further investigations to elucidate the genetic out from the cohort of healthier embryos that progress to the blastocyst stages. Our observation of increased incidence of regulation and the role of HX in embryonic metabolism during the critical periods of compaction, blastocyst formation and HX transcripts in later stage blastocysts compared with a lower incidence in morulae may partially be due to a drop-out effect, implantation may enable improvements in embryo culture conditions and the quality of human preimplantation embryos. which ultimately reduces the population of deficient embryos during the developmental selection of healthier embryos.
Ultimately this knowledge may improve the efficiency of human in-vitro fertilization and embryo transfer technology. In the populations of embryos analysed after 96 h of culture, the detection of HX mRNA in 82% of expanded blastocysts and 85% of hatched blastocysts cultured in P1 glucose/
